Posted by Michael Wonder on 29 Jul 2021
Congress presses the FDA to move faster on ALS drugs
29 July 2021 - Lawmakers pressed a top FDA official Thursday for answers on why the agency has balked at approving medicines to treat the fatal neurodegenerative condition ALS.
Two key politicians even called out specific drug candidates by name, a rare congressional boost for the biotechs behind them.
